ZHANG Tiehan, LIU Bin.
One case of tumor complicated with pneumocystis carinii pneumonia[J]. Medical Journal of the Chinese People Armed Police Forces. 2024, 35(3): 237-240
中图分类号：
R563.1
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Liu Y,Su L,Jiang S J,et al.Risk factors for mortality from pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis[J]. Oncotarget,2017, 8(35):59729-59739. [2] Fishman J A.Pneumocystis jiroveci[J].Semin Respir Crit Care Med,2020,41(1):141-157. [3] Edman J C,Kovacs J A,Masur H,et al.Ribosomal RNA sequence shows pneumocystis carinii to be a member of the fungi[J]. Nature, 1988,334(6182):519-522. [4] 冯 洁,林金杏,高 诚.卡氏肺孢子菌的生物学特性简述[J].实验动物与比较医学,2018,38(4):320-324. [5] Martinez A,Halliez M C,Aliouat M,et al.Growth and airborne transmission of cell-sorted life cycle stages of pneumocystis carinii[J]. PLoS One,2013,8(11):423. [6] Mecoli A,Danoff K.Pneumocystis jirovecii pneumonia and other infections in idiopathic inflammatory myositis[J].Curr Rheumatol Rep,2020,22(2):7-19. [7] Nureki S I,Usagawa Y,Watanabe E,et al.Veno-venous extracorporeal membrane oxygenation for severe pneumocystis ijrovecii pneumonia in an immunocompromised patient without HIV infection[J].Tohoku J Exp Med,2020,250(4):215-221. [8] Liu C J,Lee TF,Ruan S Y,et al.Clinical characteristics,treatment outcomes,and prognostic factors of pneumocystis pneumonia in non-HIV-infected patients[J].Infect Drug Resist,2019,12:1457-1467. [9] Mu X D,Jia P,Gao L,et al.Relationship between radiological stages and prognoses of pneumocystis pneumonia in non-aids immunocompromised patients[J]. Chin Med J (Engl),2016,129(17):2020-2025. [10] Rogina P,Skvarc M.Diagnostic accuracy of (1-->3)-beta-D-glucan to predict pneumocystis jirovecii pneumonia in non-HIV-infected patients[J].Radiol Oncol,2020,54(2):221-226. [11] Zhang Y,Ai J W,Cui P,et al.A cluster of cases of pneumocystis pneumonia identified by shotgun metagenomics approach[J].J Infect,2019,78(2):158-169. [12] 涂文瑶,何 娟,龙 海,等.获得性免疫缺陷综合征合并隐球菌性脑膜炎预后影响因素分析[J].贵州医科大学学报,2021,46(4):440-446. [13] 张文涛,周 萍,马晓璇,等. 免疫缺陷患者感染巨细胞病毒性肺炎的 CT 表现及临床诊疗价值[J].医学影像学杂志,2019,29(9):1491-1494. [14] Zhang F,Chen J,Huang H,et al.Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients[J].Eur J Clin Microbiol Infect Dis,2021,40 ( 9):1933-1942. [15] Tasaka S.Recent advances in the diagnosis and management of pneumocystis pneumonia[J]. Tuberc Res Dis,2020,83(2):132-140. [16] White P L,Price J S,Backx M.Therapy and management of pneumocystis jirovecii infection[J].J Fungi,2018,4(4):127. [17] Nakashima K,Aoshima M,Nakashita T,et al.Low-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected immunocompromised patients: a single-center retrospective observational cohort study[J]. J Microbiol Immunol Infect,2018,51(6):810-820. [18] Nevez G,Le G S.Caspofungin and pneumocystis pneumonia: it is time to go ahead[J]. Antimicrob Agents Chemother,2019,63(10):456. [19] Mundo W,Morales S L,Tewaha S,et al.Lower mortality associated with adjuvant corticosteroid therapy in non-HIV-infected patients with pneumonia:a single-institution retrospective US cohort study[J]. Open Forum Infect Dis,2020,7(9):ofaa354. [20] Pareja J G, Garland R, Koziel H.Use of adjunctive corticosteroids in severe adult non-HIV pneumocystis carinii pneumonia[J]. Chest,1998,113(5):1215-1224.
PDF(1235 KB)
